Search

Author/Creator Verbruggen, N.

1. Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study. Issue 6 (June 2016)

Authors:
Rizzoli, R.; Benhamou, C.-L.; Halse, J.; Miller, P.; Reid, I.; Rodríguez Portales, J.; DaSilva, C.; Kroon, R.; Verbruggen, N.; Leung, A.; Gurner, D.
Journal:
Osteoporosis international
Issue:
Volume 27:Issue 6(2016)
Page Start:
2099
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Issue 11 (November 2015)

Authors:
Bone, H.; Dempster, D.; Eisman, J.; Greenspan, S.; McClung, M.; Nakamura, T.; Papapoulos, S.; Shih, W.; Rybak-Feiglin, A.; Santora, A.; Verbruggen, N.; Leung, A.; Lombardi, A.
Journal:
Osteoporosis international
Issue:
Volume 26:Issue 11(2015)
Page Start:
2721
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search